Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT3 | P36888 | 17/20 | 0.83 |
| ▸ | CSF1R | P07333 | 16/20 | 0.83 |
| ▸ | PDGFRB | P09619 | 4/20 | 0.83 |
| ▸ | KIT | P10721 | 4/20 | 0.83 |
| ▸ | PDGFRA | P16234 | 4/20 | 0.83 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | RET | P07949 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9978679 | 0.97 | FLT3 (0.78) | FLT3CSF1RPDGFRBKITPDGFRA | |
| SCHEMBL9978708 | 0.95 | FLT3 (0.75) | FLT3CSF1RPDGFRBKITPDGFRA | |
| SCHEMBL12065999 | 0.93 | CSF1R (0.72) | FLT3CSF1RPDGFRBKITPDGFRA | |
| SCHEMBL12067857 | 0.93 | CSF1R (0.71) | FLT3CSF1RPDGFRBKITPDGFRA | |
| SCHEMBL9978587 | 0.92 | FLT3 (0.70) | FLT3CSF1RPDGFRBKITPDGFRA | |
| SCHEMBL9978872 | 0.92 | FLT3 (0.83) | FLT3CSF1RPDGFRBKITPDGFRA | |
| SCHEMBL9978768 | 0.92 | FLT3 (0.81) | FLT3CSF1RPDGFRBKITPDGFRA | |
| SCHEMBL9979112 | 0.91 | FLT3 (0.81) | FLT3CSF1RPDGFRBKITPDGFRA | |
| SCHEMBL1698611 | 0.91 | FLT3 (1.00) | FLT3CSF1RPDGFRBKITPDGFRA | |
| SCHEMBL9978770 | 0.90 | FLT3 (0.83) | FLT3CSF1RPDGFRBKITPDGFRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011150201-A2 | AZOLYL AMIDE COMPOUNDS AND METHODS OF USE THEREOF | AMBIT BIOSCIENCES CORPORATION (US) | 2011-12-01 | — | — | WO | disclosed |